One-carbon Therapeutics to Present Trial-in-Progress Poster on ODIN Phase 1/2 Study ofTH9619 at the 2026 ASCO Annual Meeting Solna, Sweden, May 29th, 2026. One-carbon Therapeutics AB, a clinical-stage Read more »
One-carbon Therapeutics Strengthens Board of Directors with Appointment of Stefan Larsson and Raj Shah Solna, Sweden, May 21, 2026. One-carbon Therapeutics AB, a clinical-stage Read more »